Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.35 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.34 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.34 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27749900 | 0.92 | TSHR (0.41) | MEN1KMT2ATHRBHTTMAPT | |
| Alcohol SCHEMBL27814340 | 0.88 | LMNA (0.40) | MEN1KMT2ATHRBHTTMAPT | |
| Alcohol SCHEMBL28195283 | 0.88 | LMNA (0.40) | MEN1KMT2ATHRBHTTMAPT | |
| Alcohol SCHEMBL28128665 | 0.88 | LMNA (0.40) | MEN1KMT2ATHRBHTTMAPT | |
| Alcohol SCHEMBL28139922 | 0.86 | LMNA (0.39) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL27455101 | 0.86 | LPAR3 (0.38) | MEN1KMT2ATHRBHTTMAPT | |
| Alcohol SCHEMBL28272785 | 0.86 | LMNA (0.39) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL6930631 | 0.86 | LPAR3 (0.38) | MEN1KMT2ATHRBHTTMAPT | |
| Methyl Alcohol SCHEMBL27875400 | 0.86 | LMNA (0.39) | MEN1KMT2ATHRBHTTLMNA | |
| SCHEMBL6534000 | 0.85 | TSHR (0.42) | MEN1KMT2ATHRBLMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080009644-A1 | Organosilicon Compounds | ZYDEX INDUSTRIES | 2008-01-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080009644-A1 | Organosilicon Compounds | CUL1, CUL3, MGAM | MEN1 1105/4885KMT2A 2317/4885THRB 4707/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.